# Eyenuk > EyeArt autonomous AI detects vision-threatening diabetic retinopathy in seconds. FDA 510(k)-cleared technology enabling non-invasive retinal screening at the point of care with 96-97% sensitivity. Location: United States ## Categories - Other Businesses & Services ## Services - Advanced Grading Tools - Autonomous DR Detection (mtmDR and vtDR) - Care Coordination - Clinical Triage and Expert Review - Compliance and Audit Readiness - Diabetic Retinopathy Screening - EHR Integration - Expert Human Review - Longitudinal Comparison - Longitudinal Disease Monitoring and Specialist Review - Multi-Camera Compatibility - Multi-Condition Detection - Network-Wide Reporting - Objective Risk Stratification - Program Compliance - Systemic Health Insights ## Documents - [Business profile](https://directory.websdocs.com/business/eyenuk) - [Directory JSON](https://directory.websdocs.com/business/eyenuk.json) - [Schema.org JSON-LD](https://directory.websdocs.com/business/eyenuk/schema.jsonld) - [Directory sitemap](https://directory.websdocs.com/sitemap.xml) - [Directory discovery manifest](https://directory.websdocs.com/.well-known/asg-directory.json) - [Directory OpenAPI](https://directory.websdocs.com/api/openapi.json) - [Official website](https://www.eyenuk.com/)